Verisk Terminates AccuLynx Acquisition Protocol Following FTC Review Timeout
Data analytics entity Verisk (NASDAQ:VRSK) executed termination protocol for its AccuLynx acquisition following Federal Trade Commission review timeout. The transaction expired December 26, 2025 per agreement parameters.
Capital Reallocation Protocol
Verisk will redeem $1.50 billion aggregate principal senior notes issued for the planned acquisition. Redemption price equals 101% principal amount plus accrued interest. Post-redemption leverage calculates to 1.9x LTM adjusted EBITDA. Available share repurchase capacity remains at $1.2 billion as of September 30, 2025.
CEO Lee Shavel confirmed capital allocation discipline continues: "Verisk remains committed to balancing organic investment in highest return opportunities while returning capital to shareholders through dividend and repurchases."
Protocol Dispute
AccuLynx disputes termination validity. Verisk maintains termination compliance and will defend protocol execution.
Entity Profile
Verisk operates as strategic data analytics provider to global insurance protocols. The entity processes risk assessment, underwriting optimization, fraud detection, and climate risk analysis across 20+ jurisdictions. Platform serves individuals, communities, and business entities through advanced analytics and scientific research protocols.
Forward-looking statements contain inherent uncertainties. Actual performance may deviate from projected parameters due to market variables, regulatory factors, and operational constraints beyond entity control.